No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
INGR240517C120000
- 1.00
- +0.55+122.22%
15min DelayClose May 10 16:00 ET
1.00High0.70Low
0.70Open0.45Pre Close2 Volume123 Open Interest120.00Strike Price170.00Turnover17.96%IV0.77%PremiumMay 17, 2024Expiry Date0.22Intrinsic Value100Multiplier4DDays to Expiry0.78Time Value100Contract SizeAmericanOptions Type0.5527Delta0.1590Gamma104.54Leverage Ratio-0.1167Theta0.0087Rho57.78Eff Leverage0.0548Vega
Intraday
- 5D
- 1D
News
11 Best Farmland and Agriculture Stocks To Buy According to Analysts
Ingredion(INGR.US) Officer Sells US$282.18K in Common Stock
$Ingredion(INGR.US)$ Officer Fernandes Larry sold 2,369 shares of common stock on May 9, 2024 at an average price of $119.115 for a total value of $282.18K.Source: Announcement What is statement of ch
Ingredion Insider Sold Shares Worth $282,183, According to a Recent SEC Filing
Larry Fernandes, Senior Vice President, Chief Commercial & Sustainability Officer, on May 09, 2024, sold 2,369 shares in Ingredion (INGR) for $282,183. Following the Form 4 filing with the SEC, Fernan
Demystifying Ingredion: Insights From 4 Analyst Reviews
Analysts' ratings for Ingredion (NYSE:INGR) over the last quarter vary from bullish to bearish, as provided by 4 analysts.The following table encapsulates their recent ratings, offering a glimpse into
Ingredion Incorporated (NYSE:INGR) Q1 2024 Earnings Call Transcript
Form 144 | Ingredion(INGR.US) Officer Proposes to Sell 282.18K in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Ingredion(INGR.US)$ Officer LARRY FERNANDES intends to sell 2,369 shares of its common stock on May 9, with a total market value of approximately $282.18K. Source: A
Comments
Ingredion's dividend is sustainable, backed by profits and cash flow. Its EPS growth and low payout ratio indicate investment in growth. Faster earnings growth would be ideal. It's a good dividend investment candidate, but risks exist.
Should You Buy Ingredion Incorporated (NYSE:INGR) For Its Upcoming Dividend? 1
Despite Ingredion's low PE ratio, the risk of negative growth looms. Investors should ponder on increasing exposure to Ingredion or diversifying. Further research is advised, considering the risks of future negative growth.
1
Analysts' optimism dwindles as they predict a revenue drop while EPS remains steady. The narrow estimate spread suggests easy valuation or strong views on future prospects. The consensus price target remains steady, indicating no major change in business prospects. However, Ingredion's revenues are expected to underperform the wider industry.
Ingredion's lower trading price relative to industry peers coupled with a strong future earnings growth outlook presents an enticing investment opportunity. Other aspects like capital structure require examination for a well-informed decision.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Novo-Nordisk A/S(NVO.US$ - up 13.4%
2. $Eli Lilly and Co(LLY.US$ - up 10.5%
3. $James Hardie Industries(JHX.US$ - up 10.1%
4. $New York Times(NYT.US$ - up 3.3%
5. $POSCO(PKX.US$ - up 2.9%
6. $Fox Corp-B(FOX.US$ - up 2.8%
7. $Fox Corp-A(FOXA.US$ - up 2.8%
8. $West Pharmaceutical Services(WST.US$ - up 2.5...
Gap Ups
1. $Novo-Nordisk A/S(NVO.US$ - up 13.4%
2. $Eli Lilly and Co(LLY.US$ - up 10.5%
3. $James Hardie Industries(JHX.US$ - up 10.1%
4. $New York Times(NYT.US$ - up 3.3%
5. $POSCO(PKX.US$ - up 2.9%
6. $Fox Corp-B(FOX.US$ - up 2.8%
7. $Fox Corp-A(FOXA.US$ - up 2.8%
8. $West Pharmaceutical Services(WST.US$ - up 2.5...
+17
10
Read more